According to Arcutis Biotherapeutics's latest financial reports the company's current EPS (TTM) is -$5.54. In 2022 the company made an earnings per share (EPS) of -$5.65 a decrease over its 2021 EPS that were of -$4.16.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$5.54 | -1.95% |
2022 | -$5.65 | 35.82% |
2021 | -$4.16 | 8.33% |
2020 | -$3.84 | 92.96% |
2019 | -$1.99 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -60.65% | ๐บ๐ธ USA |